- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about DGX
Recent news which mentions DGX
Earnings Scheduled For October 21, 2021
October 21, 2021
From Benzinga
Why Shares of Ginkgo Bioworks Plunged Today
October 20, 2021
From Motley Fool
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
October 18, 2021
From Benzinga
Overview Of Value Stocks In The Healthcare Sector
October 04, 2021
From Benzinga
The Delta Variant Has Made Quest Diagnostics Indispensable
September 29, 2021
From Motley Fool
7 of the Best Penny Stocks to Buy Coming Into Year-End
September 21, 2021
From InvestorPlace
Instead of Buying Dogecoin, Invest in These 3 Companies That Are Bullish on Blockchain Technology
September 16, 2021
From Motley Fool
TTOO Stock: The Huge Covid-19 News Lifting T2 Biosystems Today
September 10, 2021
From InvestorPlace
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
September 10, 2021
From Benzinga
Quest Diagnostics Updates 2021 Outlook On Surging Demand Of COVID-19 Tests
September 09, 2021
Tickers
DGX
From Benzinga
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
From Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
From Benzinga
Underwhelming: Tepid Jobs Data Could Add New Variable To Fed Policy Equation
September 03, 2021
From Benzinga
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
September 03, 2021
From Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
From Benzinga
10 Biggest Price Target Changes For Wednesday
September 01, 2021
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
August 17, 2021
From Benzinga
From Benzinga
Quest Diagnostics, eMed Team Up To Offer COVID-19 Rapid Antigen Testing At Workplaces
August 11, 2021
Tickers
DGX
From Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
From Benzinga
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
August 03, 2021
From Benzinga
Tickers
DGX
From Motley Fool
Tickers
DGX
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.